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Abstract
Background: Paramyxoviruses are assembled at the plasma membrane budding sites after synthesis of all the structural
components in the cytoplasm. Although viral ribonuclocapsid (vRNP) is an essential component of infectious virions, the
process of vRNP translocation to assembly sites is poorly understood.
Methodology/Principal Findings: To analyze real-time trafficking of vRNPs in live infected cells, we created a recombinant
Sendai virus (SeV), rSeVLeGFP, which expresses L protein fused to enhanced green fluorescent protein (eGFP). The
rSeVLeGFP showed similar growth kinetics compared to wt SeV, and newly synthesized LeGFP could be detected as early as
8 h postinfection. The majority of LeGFP co-localized with other components of vRNPs, NP and P proteins, suggesting the
fluorescent signals of LeGFP represent the locations of vRNPs. Analysis of LeGFP movement using time-lapse digital video
microscopy revealed directional and saltatory movement of LeGFP along microtubules. Treatment of the cells with
nocodazole restricted vRNP movement and reduced progeny virion production without affecting viral protein synthesis,
suggesting the role of microtubules in vRNP trafficking and virus assembly. Further study with an electron microscope
showed close association of vRNPs with intracellular vesicles present in infected cells. In addition, the vRNPs co-localized
with Rab11a protein, which is known to regulate the recycling endocytosis pathway and Golgi-to-plasma membrane
trafficking. Simultaneous movement between LeGFP and Rab11a was also observed in infected cells, which constitutively
express mRFP-tagged Rab11a. Involvement of recycling endosomes in vRNP translocation was also suggested by the fact
that vRNPs move concomitantly with recycling transferrin labeled with Alexa 594.
Conclusions/Significance: Collectively, our results strongly suggest a previously unrecognized involvement of the
intracellular vesicular trafficking pathway in vRNP translocation and provide new insights into the transport of viral
structural components to the assembly sites of enveloped viruses.
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Introduction
Sendai virus (SeV) is a pneumotropic murine pathogen in the
Paramyxoviridae family, which includes many clinically important
human pathogens [1]. It is an enveloped negative-strand RNA virus
and encodes 6 major structural proteins: two glycoproteins (HN and
F), the matrix (M) protein, the nucleoprotein (NP), and the
phosphoprotein (P) and large (L) proteins, which make up the
polymerase complex. The viral RNA (vRNA) is encapsidated by NP,
and the P-L polymerase complex associates with the vRNA-NP
complex toformribonucleocapsids(vRNPs).The polymerasecomplex
is responsible for transcription and replication of the viral genome,
which occurs completely in the cytoplasm of infected cells. Newly
synthesized structural components includingvRNPs are transported to
the plasma membrane, where progeny viruses are assembled and
formed by budding. At the budding sites, vRNPs are wrapped by a
lipid bilayer envelope containing an internal M layer and the HN and
F spike proteins, which are exposed on the virion surface [1].
Although components of virions must translocate to budding
sites for progeny virion formation, little is known about the
mechanism of how viral structural components are transported to
the plasma membrane for assembly. Among the viral structural
proteins, M protein, which lines the inner surface of the host cell’s
plasma membrane, is well established as playing a key role in
virion assembly. Expression of M protein alone induces budding,
and it interacts with specific envelope glycoproteins and vRNPs
[2]. The association between SeV M and glycoproteins seems to
be required for M trafficking to budding sites, since restriction of
glycoproteins at the Golgi compartment by monensin or low
temperature incubation resulted in accumulation of M protein on
Golgi membranes [3]. This suggests that M utilizes trafficking of
envelope glycoproteins through the secretory pathway for its
translocation to the plasma membrane. Similarly, a specific M-
vRNP interaction is required for the uptake and incorporation of
vRNPs into progeny virions at the plasma membrane [4],
however, it is not clear whether vRNPs interact with M during
translocation through the cytosol or upon reaching the plasma
membrane.
Two cytoskeletal elements, the microtubule (MT) and actin
networks, support motor protein-driven intracellular transport,
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e10994including vesicles and organelles. In animal cells, MTs provide
high-speed, long-range transport. Most intracellular transport
occurs via the MT network. Some recent studies suggest that
cellular MT motors catalyze the intracellular transport of viral
core structures during the entry process of both DNA and RNA
viruses; examples are herpes simplex virus [5], human cytomeg-
alovirus [6], parvoviruses [7–8], human immunodeficiency virus
[9], influenza A virus [10], and vesicular stomatitis virus (VSV)
[11]. Using a yeast two-hybrid cDNA library screen, rabies virus P
protein was found to interact strongly with the cytoplasmic dynein
light chain, a component of both MT- and actin-based motors
[12–14]. Moreover, the matrix protein present in the cytosolic
Gag polyprotein of many retroviruses binds to kinesin-4 [15], and
this interaction is suggested to convey subviral particles to the
plasma membrane for virus budding. These studies suggest that
the cellular trafficking system that utilizes MTs may have
important roles for many viruses during assembly and egress. In
the case of paramyxoviruses, however, little is known about the
role of the MT network in virus assembly.
An additional facet of cellular trafficking involves transport of
cellular cargo by vesicles. Vesicular transport of cargo within the
cell is tightly regulated and characteristically is facilitated by the
use of vesicles that bud from a donor compartment and fuse with
an acceptor compartment. Vesicular transport specificity and
fidelity are directed by vesicular membrane proteins and small
molecular weight Rab GTPases [16]. Rab proteins are specific for
various membranes, and the specificity is mediated by Rab
interactions with effector molecules [17–18]. Two examples of
Rab proteins, Rab8 and Rab11, have been shown to be vital for
transporting cargo from the Golgi to the plasma membrane
[19–21]. Inhibition of these proteins disrupts recycling endosome-
dependent transport from the Golgi to the plasma membrane [21].
Rab8 has been shown to be involved in transport of the
glycoproteins of VSV and Semliki Forest virus to the cell surface
[22–23], while both Rab8 and Rab11 play a role in hantavirus
release [24]. As with the role of MTs in transport of
paramyxovirus RNPs to sites of assembly, the role of the vesicular
trafficking pathways in paramyxovirus assembly has not been
identified.
The real-time visualization of virus particles or viral structural
components in live cells provides an abundance of information
about the life cycle of the viruses. A widely used approach for the
visualization of viral components is to rescue recombinant viruses
which express a structural protein fused to a fluorescent protein,
such as enhanced green fluorescent protein (eGFP). This approach
has been successfully utilized to track virions or viral proteins in
infected cells. To study the translocation process of vRNPs in live
cells, we rescued a recombinant SeV, rSeVLeGFP, which
expresses the L protein fused to eGFP. Analysis of cells infected
with rSeVLeGFP showed vRNPs trafficking on the MT network.
Disruption of MT structure by nocodazole immobilized vRNP
movement and reduced the production of progeny virions without
affecting viral protein levels in infected cells, suggesting that
trafficking through MTs is required for the assembly of progeny
virions. Additional study using electron microscopy (EM) revealed
close association of vRNPs with intracellular vesicles, which
appear to be abundant in virus-infected cells. The vRNPs in cells
also co-localized with Rab11a, a known regulator of the recycling
endosome pathway. In addition, concomitant movement of
vRNPs with transferrin and with Rab11a was observed. Our data
suggest that SeV vRNPs traffic through the cytoplasm using
intracellular vesicles along the MT network, which is likely to lead
to the translocation of vRNP to viral assembly/budding sites at the
plasma membrane of infected cells.
Results
Rescue and characterization of rSeVLeGFP
To visualize movement of vRNPs in the cytoplasm of infected
cells, we fused SeV L protein gene with the eGFP gene (LeGFP),
and cloned this fusion gene into the full genome SeV cDNA
(Figure 1A). Using the reverse genetics rescue system, the
recombinant virus rSeVLeGFP that expresses LeGFP was
successfully rescued. The expression of the LeGFP protein was
determined by Western blotting analysis, using an anti-GFP
antibody. As a control for eGFP expression, we rescued another
recombinant SeV, rSeV-eGFP, which expresses free eGFP that is
not fused to any viral protein, from an additional gene inserted
between the F and HN genes. As shown in Figure 1B, only a single
specific band of LeGFP was detected, confirming that eGFP
signals in infected cells represent LeGFP and not the non-fused
eGFP, which could be produced by cellular proteases. We next
determined the appearance of fluorescent signals at various times
after infection. We used HeLa cells because they have an
expansive cytoplasm and are known to support SeV growth
[25]. HeLa cells infected with rSeVLeGFP at an MOI of 1.0 were
observed with a fluorescent microscope at various times after
infection (Figure 1C). Fluorescent signals of LeGFP could be
detected as early as 8 h after infection, and by 12 h numerous
individual dots of strong fluorescent signals were visible. At 24 h,
in addition to the small dots, larger signals of fluorescence were
also evident. The fluorescent punctae, which appeared in
rSeVLeGFP-infected cells were clearly distinguishable from the
diffuse signals of eGFP observed in cells infected with rSeV-eGFP
that expresses non-tagged free eGFP from an additional gene
(Figure 1C). L protein forms a polymerase complex with P protein
and associates with nucleocapsids composed of viral RNA and NP.
Using confocal microscopy, we next determined the co-localiza-
tion of LeGFP with P and NP proteins to confirm that LeGFPs are
associated with nucleocapsids. HeLa cells infected with rSeV-
LeGFP for 24 h were fixed, permeabilized and reacted with anti-
NP, anti-P or anti-F monoclonal antibodies (Mab) followed by
anti-mouse IgG-Texas Red. The results of the 3-D confocal
analysis revealed that LeGFP co-localized well with P and NP, but
not F proteins (Figure 1D). Detailed graphic analysis comparing
the intensity of individual fluorescent pixels indicated that 91.5%
and 77.9% of LeGFP co-localized with P and NP, respectively.
These data contrasted distinctly to the limited co-localization
calculated between LeGFP and F glycoprotein at around 25.3%
(Figure 1D bottom panels), and confirm that the majority of
LeGFPs detected in the cytoplasm are associated with viral
nucleocapsids.
To ascertain whether the fusion of eGFP to the C-terminus of L
protein would interfere with viral replication and growth, we
compared the growth kinetics of wt SeV and rSeVLeGFP in LLC-
MK2 cells. The cells were infected with the viruses at an MOI of
0.01 and cultured with trypsin for 84 h. The rSeVLeGFP grew to
a similar titer as wt SeV in the cell line (Figure 1E), indicating the
presence of eGFP at the C-terminus of L protein does not
significantly inhibit the function of SeV L protein. Furthermore,
we compared the production of the vRNP complex in wt SeV- and
rSeVLeGFP-infected cells by radioimmunoprecipitation using
anti-NP Mab. The vRNPs composed of NP, P and LeGFP were
recovered from rSeVLeGFP-infected cells at a similar molecular
ratio to that recovered from wt SeV-infected cells (Figure 1F left).
Also, purified rSeVLeGFP virions contained vRNPs with a similar
molecular ratio of NP, P and L as that detected from wt SeV (right
panel). These results indicate that fusion of eGFP to the C-
terminus of L protein does not significantly affect the function,
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fluorescent signals of rSeVLeGFP-infected cells represent the viral
polymerase complex in association with vRNPs.
LeGFP movement in live cells
To ascertain the type of movement vRNPs exhibit in live
infected cells, we recorded the trafficking of LeGFP using digital
video microscopy. Movement of vRNPs through the cytoplasm of
infected cells was observed under fluorescent microscope, and
images were collected at 1 frame per sec, with an exposure time of
0.5 sec (Figure 2A, B and Video S1). Capturing 1 frame per sec
facilitated following the movement of distinct fluorescent particles
traveling within the same focal plane. We observed a large number
of small fluorescent dots traveling throughout the cytoplasm.
These dots exhibited directional and saltatory movement. The
small fluorescent dots also moved into and out of larger
accumulations of fluorescent signal. Some small fluorescent dots
were released from the large areas of accumulated vRNP and
traveled in various directions. Most of the fluorescent dots
traveling a long distance were small in size, and little movement
of large aggregates was observed.
The directional, saltatory movement of the fluorescent LeGFP
particles is suggestive of microtubule (MT)-dependent transport,
which has been reported with VSV [11]. To determine if LeGFPs
move alongside MT structure, we infected HeLa cells with
rSeVLeGFP, and at 18 h post infection, cellular MT structure was
visualized with Tubulin Tracker Green, a microtubule binding
protein (Taxol) labeled with Alexa Fluor 488, which allows live cell
imaging of MTs (Figure 3 and Video S2). The cell at the bottom
right of Figure 3A is uninfected and shows MT staining only, and
the cell on the left of the panel exhibits a multitude of fluorescent
LeGFP particles associated with MTs. Digital video microscopy
analysis clearly showed vRNP movement along MTs. Figure 3B
represents a successive frame analysis of vRNP movement,
Figure 1. Rescue and characterization of rSeVLeGFP. (A) Schematic diagram of rSeVLeGFP genome. The rSeVLeGFP genome expresses eGFP
(239 residues) fused to the C-terminus of the L protein (2,228 residues). (B) Western blot analysis of LeGFP expressed in infected cells. Lysates of
mock- (lane 1), rSeVLeGFP- (lane 2), or rSeV-eGFP- (lane 3) infected cells were reacted with anti-GFP antibody. (C) Analysis of LeGFP localization in live
cells. HeLa cells were infected with rSeVLeGFP and images of the cells were captured at the indicated h p.i. The same settings for the fluorescent
microscope were used at each time point. (D) Co-localization of SeV NP, P and F proteins with LeGFP. HeLa cells were infected with rSeVLeGFP for
24 h. Fixed cells were stained for NP, P or F using specific Mabs. SeV NP, P or F are shown in red and LeGFP in green. Merged images in the top row
are deconvoluted z-stack images of the xy plane, and the images in the second row are z-axis reconstructions, taken across the xy plane at the white
boxed region of interest, shown in the top row. The bottom row of graphs represents overlapping degree of intensity scatterplots of each pixel in the
image, as determined by the Olympus FV1000 software. Yellow lines represent the threshold set at 2500. (E) Growth kinetics of rSeVLeGFP as
compared with wt SeV. LLC-MK2 cells were infected at MOI 0.01 with rSeVLeGFP (gray triangle) or wt SeV (closed square) and incubated at 34uC.
Aliquots of infected-cell supernatants were collected and viral titers of supernatants were determined in LLC-MK2 cells. (F) Characterization of viral
proteins in purified virions and cell lysates of infected cells. HeLa cells were infected with either SeV or rSeVLeGFP and labeled with
35S-Met/Cys. SeV
or rSeVLeGFP vRNP complexes in infected cells were immunoprecipitated by anti-NP Mab and analyzed by SDS-PAGE. Virions in the supernatants
were purified and analyzed by SDS-PAGE.
doi:10.1371/journal.pone.0010994.g001
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MT structure. We tracked the movement of multiple particles to
determine the average particle velocities. The average velocities of
LeGFPs which traveled greater than 2 mm in length were 0.41–
1.04 mm/sec, which is consistent with reported MT cargo
movement of 0.2–2.7 mm/sec [26].
Role of microtubules in trafficking vRNPs through the
cytoplasm
To determine the role of MTs in vRNP trafficking, we treated
infected cells with the MT destabilizing drug, nocodazole.
Nocodazole was added to rSeVLeGFP-infected cells at 18 h post
infection, and after 1 h treatment, movement of vRNP was
recorded by digital video microscopy (Figure 3C, 3D and Video
S3). In the nocodazole treated cells, LeGFP particles exhibited no
movement, besides simple Brownian motion. Upon removal of the
drug and replacement with fresh medium, the particles resumed
their previously described movement (data not shown).
To further characterize the role of MT in SeV replication and
assembly, infected cells were labeled with
35S-Met/Cys for 16 h in
the presence or absence of nocodazole. The progeny virions
released into the culture medium were collected, purified and
analyzed by SDS-PAGE. As shown in Figure 4A, nocodazole
treatment reduced production and release of progeny virions into
the medium. Viral protein synthesis was not affected by
nocodazole treatment (Figure 4B), suggesting the role of MT in
viral assembly. Effect of nocodazole on virus production was also
determined in LLC-MK2 cells. Cells infected with SeV for 4 h
were either treated with or without nocodazole for 20 h, and the
amounts of infectious viruses in medium were determined.
Consistent with the result of virion production in HeLa cells, the
amount of infectious virus was decreased 63% in the presence of
nocodazole. These data indicate that vRNPs utilize MT structure
for their translocation inside the cytoplasm, which is likely to be
required for efficient assembly and release of progeny virions.
Involvement of vesicular trafficking pathways in vRNP
translocation
To gain a detailed insight into nucleocapsid transport, we
examined vRNP localization in infected cells by ultrastructural
analysis using electron microscopy (EM). HeLa cells were infected
with SeV or left uninfected for 18 h, and processed for EM
analysis, as described in the Materials and Methods. Ultrathin
sections of the epoxy resin embedded infected or uninfected cells
were compared by transmission electron microscopy. Compared
with the uninfected cells, SeV-infected cells exhibited a significant
increase in the number of vesicles present in the cytoplasm
(Figure 5A and B). Images of infected cells indicated many
nucleocapsid-like structures located close to intracellular vesicles
(Figure 5C). To confirm vRNP association to cellular vesicles, we
performed immuno-EM analysis using anti-NP specific Mab. We
did both pre-embedded labeling using horseradish peroxidase
(HRP) and 3, 39-Diaminobenzidine (DAB) staining and post-
embedded labeling using immuno-gold beads. In SeV-infected
cells, many NP signals were detected in areas around vesicles
(Figure 5D, E and F). We observed vesicles close to the large
vRNP accumulates (Figure 5E), as well as the vesicles associated
with vRNPs around the vesicular membrane (Figure 5F). The
uninfected cells, in contrast, did not have noticeable DAB staining
or immuno-gold particles (data not shown). The heavy concen-
tration of NP around vesicles in infected cells is likely to signify that
vRNPs are utilizing these vesicles for transport to assembly sites for
incorporation into virions.
Association of vRNP with cellular membrane vesicles was also
determined by membrane flotation assay. Infected cell lysate in
71.5% sucrose solution was overlayed with 55% and 10% sucrose
solutions, and after ultracentrifugation, 13 fractions were collected
and the presence of NP in the fractions was determined by
Western blot analysis using anti-SeV polyclonal serum. Approx-
imately 35% of NP was recovered from membrane associated
fractions (Figure 6, fractions 3 and 4), which seems to be a
reasonable proportion based on the population of vRNPs in
motion in live cells (Figure 2). These membrane-bound NP also
fractionated with P, as detected by the polyclonal serum. Since
many intracellular vesicles like endosomes, lysosomes, and
secretory vesicles move along MTs [17], our overall results suggest
that the vesicular trafficking pathway is involved in the
translocation of vRNPs.
Co-localization and concomitant movement of vRNP
with Rab11a
Members of the Rab GTPase family serve as master regulators
of vesicular membrane transport on both the exo- and endocytic
pathways. Rab8 and Rab11 have been identified as regulators of
vesicular trafficking by recycling endosomes or exocytosis from the
trans-Golgi network to the cell surface [16]. To further
Figure 2. Live cell imaging of LeGFP particle movements. HeLa cells were infected with rSeVLeGFP for 18 h. Images were collected at 1 frame
per sec, with an exposure time of 0.5 sec. (A) Typical trafficking of vRNPs. Positions of 5 different LeGFP signals every 4 seconds are shown. (B)
Montage of the movement of LeGFP signal #4 is shown. The circles indicate the same LeGFP signal (#4) in (A) in successive frames. The images are
selected frames from a video (Video S1).
doi:10.1371/journal.pone.0010994.g002
Trafficking of SeV vRNP
PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e10994characterize the vesicular trafficking pathway that vRNPs may
utilize for translocation, we created two cDNA constructs,
pmRFP-Rab8a and pmRFP-Rab11a, which express monomeric
red fluorescent protein (mRFP) fused to Rab8a or Rab11a
(Figure 7A). Expression of these fusion proteins was confirmed
by Western blot analysis, showing the presence of appropriate size
products and not mRFP alone in transfected cell lysates
(Figure 7B). We determined the localization of the mRFP-Rab
proteins in rSeVLeGFP-infected cells by confocal microscope.
There was no co-localization observed between mRFP-Rab8a and
LeGFP (Figure 7C). In sharp contrast, mRFP-Rab11a clearly co-
localized with LeGFP (Figure 7D). Statistical analysis of the
overlapping degree of intensity generated by the Olympus
Confocal FV1000 Software shows 42% of the overall mRFP-
Rab11a signals and 30% of the LeGFP signals are co-localized.
The mRFP-Rab11a was associated with both small and large
vRNP signals in the cytoplasm. We next visualized movement of
SeV vRNPs along with mRFP-Rab11a in live cells by digital video
microscopy performed on a confocal microscope. To facilitate the
live cell analysis, we first established a HeLa cell line that
constitutively expresses mRFP-Rab11a. HeLa-mRFP-Rab11a
cells were infected with rSeVLeGFP, and we observed the
movement of both mRFP-Rab11a and SeV vRNPs in live cells.
Many of the mRFP-Rab11a were found to move concomitantly
with small vRNP particles (Figure 8A, 8C and Video S4), in a
manner consistent with movement along MTs. Together with the
EM and membrane flotation assays, these results suggest that the
vesicular trafficking pathway regulated by Rab11a is involved in
vRNP trafficking.
Movement of vRNPs with transferrin in live cells
Rab11 is well characterized for its role in regulating membrane
traffic from the endocytic recycling compartment to either the
plasma membrane or the trans-Golgi network [21,27]. To
further determine the involvement of recycling endosomes in
vRNP trafficking, we visualized vRNP movement along with
Figure 3. Tracking LeGFP movement in live cells along MT structures. HeLa cells were infected at MOI 0.5 and treated with 250 nM Tubulin
Tracker Green at 18 h p.i. Images were collected by digital video microscopy. (A) Image of rSeVLeGFP-infected cell (left), which shows both LeGFP and
microtubules. The white rectangle represents the area of the infected cell that was used to make the time-lapse series shown in (B). Bar, 10 mm. (B)
Single frame images of LeGFP particle movement along MT structures over time. The arrows indicate movement of the same LeGFP particle along
microtubules. (C) Effect of nocodazole treatment on LeGFP trafficking. Infected HeLa cells were treated with 10 mg/ml nocodazole for 1 h at 18 h p.i.,
and then stained with Tubulin Tracker Green. (D) Single frame images of nocodazole-treated cells, showing no movement of LeGFP.
doi:10.1371/journal.pone.0010994.g003
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quintessential markers of recycling endosomes. Movement of the
transferrin receptor along the recycling endosome pathway is
known to be regulated by the activation of Rab11, which is
required for direct recycling from the sorting endosome to the cell
surface [28]. HeLa cells infected with rSeVLeGFP were incubated
with fluorescently labeled transferrin, and trafficking of LeGFP
and transferrin in live cells was recorded using confocal digital
video microscopy. The transferrin movement was very similar to
that of mRFP-Rab11a and vRNPs, which was directional and
saltatory, indicative of translocation along MTs. In addition to
individual movement, we detected concomitant movement of
recycling transferrin with vRNP (Figure 8B and D, Video S5).
These data provide additional corroboration that SeV vRNPs
utilize recycling endosomes for transport from the cytoplasm to
assembly sites at the plasma membrane.
Discussion
The paramyxovirus infection is initiated by virus attachment,
followed by membrane fusion at the plasma membrane and
subsequent release of vRNP into the cytoplasm of the cell. The
vRNP serves as a template for transcription and replication of the
genome. With rSeVLeGFP that expresses L protein fused with
eGFP (LeGFP), we could visualize the synthesis and intracellular
movement of vRNPs in live infected cells. The LeGFP signals were
detected as early as 8 h p.i., and at 12 h p.i., the signals were easily
visualized with most forming tiny dots. It is unlikely that vRNPs
are formed at particular limited locations in the cytoplasm because
NP-P-L complexes appear all over the cytoplasm of infected cells
(Figure 1D). There are many NP or P not co-localized with LeGFP
(Figure 1D). However, over 90% and almost 80% of LeGFP co-
localized with P and NP, respectively, suggesting that the majority
of LeGFP in infected cells are associated with nucleocapsid
complex. Because the level of LeGFP co-localization with NP was
slightly less than that with P, it is likely that a small portion of the
LeGFP exists as a complex with only P. Previous studies have
demonstrated that P can bind NP alone, behaving as a chaperone
for NP, preventing NP self-assembly into nucleocapsid-like
complexes [29–30]. Therefore, it is reasonable to detect NP or P
not associated with LeGFP in infected cells (Figure 1D). Although
the majority of LeGFP was detected in association with NP and P,
it is not known whether all the nucleocapsids contain viral genomic
RNA in the complex. However, the NP-P complex is known to act
as a substrate for viral RNA encapsidation. P and L complexes
have also been suggested as necessary precursors to association
with nucleocapsid template for replication [31]. Therefore,
extensive co-localization of LeGFP with NP strongly suggests that
the majority of LeGFP signals we observed represent vRNPs.
At an early stage of infection, we detected many LeGFP dots
throughout the cytoplasm. Late after infection, large accumula-
tions of LeGFP signals became evident (Figure 1C). Appearance of
the accumulated vRNPs may indicate the presence of particular
sites in the cytoplasm which provide an environment for enhanced
formation of progeny vRNPs late after infection. Other negative
strand RNA viruses also exhibit nucleocapsid accumulations in the
cytoplasm of infected cells, such as Negri bodies, which are
considered to be genome replication sites formed during the early
stages of rabies virus infection. A recent study indicates that the
initial large Negri bodies, of which only a couple appear per cell,
Figure 4. Nocodazole treatment does not affect protein synthesis, but reduces progeny virion production. (A) Progeny
35S-labeled SeV
virions produced from infected cells cultured in the presence or absence of nocodazole were purified and analyzed by SDS-PAGE. (B) Level of NP
proteins in nocodazole-treated or non-treated HeLa cells was compared by Western blotting using anti-NP Mab. Same amounts of cell lysates were
used for comparison. (C) Supernatants from SeV-infected LLC-MK2 cells cultured in the presence or absence of nocodazole were collected and
infectious viral titer was determined by plaque assay. Noc: nocodazole.
doi:10.1371/journal.pone.0010994.g004
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(A) or infected (B) with SeV for 18 h at MOI 3.0. Ultra-thin sections were stained with uranyl acetate and lead citrate. Note that infected cell (B)
contains many vesicles, which are not observed in uninfected cells (A). Bars, 2 mm. (C) EM image showing nucleocapsid-like structures close to or
associated with vesicles. Arrows indicate nucleocapsid-like structures, many of which are associated with vesicles. Bar, 500 nm. (D) NP staining of SeV-
infected HeLa cells. Fixed and permeabilized cells were reacted with anti-SeV NP cocktail and goat anti-mouse IgG HRP, followed by DAB staining.
Arrows denote examples of NP localization visualized by DAB precipitate. Bar, 200 nm. (E and F) Detection of NP by EM using immuno-gold beads.
Sections of infected cells were reacted with anti-SeV NP Mab, then with goat anti-mouse 12 nm gold beads. (E) A cellular vesicle located close to an
accumulated NP. Bar, 500 nm. (F) NP localized around a vesicular structure. Bar, 200 nm. V, vesicles. N, nucleus.
doi:10.1371/journal.pone.0010994.g005
Trafficking of SeV vRNP
PLoS ONE | www.plosone.org 7 June 2010 | Volume 5 | Issue 6 | e10994gradually decrease in size with an increase in the appearance of
many small nucleocapsid structures over the course of infection
[32]. In contrast to rabies virus, numerous SeV vRNPs appear
throughout the cytoplasm during the early stages of infection and
gradually accumulate over time. It is therefore possible that SeV
vRNPs accumulate at specific locations during their translocation.
We observed small fluorescing dots (vRNP) coming out of the large
clusters and moving in a directional manner. We also observed
some small dots traveling long distances and merging into larger
vRNP clusters (Figure 2 and Video S1). These varied movements
of vRNPs going into and coming out of large vRNP accumu-
lations may suggest the involvement of multiple steps in vRNP
trafficking.
The directional movement strongly suggests that vRNPs utilize
a specific intracellular trafficking pathway for their translocation,
instead of moving by diffusion, which is severely restricted for
macromolecular transport in the cytoplasm [33–34]. By staining
MT in live rSeVLeGFP-infected cells, we were able to capture
vRNP movement alongside MT, clearly showing vRNP trafficking
through a MT-based mechanism (Figure 3A and B, Video S2).
Nocodazole treatment restricted the movement of vRNP
(Figure 3C and D, Video S3), and reduced production of progeny
virions (Figure 4), supporting the idea that trafficking of SeV
vRNPs through MT is involved in the assembly process of progeny
virion formation at the plasma membrane. MT motors have been
shown to catalyze the intracellular transport of many viral
structures [35–36]. There are two alternative strategies viruses
utilize for transport, either direct interaction of viral components
with MT motors or hijacking cytoplasmic vesicular traffic [36]. It
is possible that SeV vRNPs directly interact with kinesin motors
and are transported by these motors on MT tracks; however, we
were unable to detect direct interaction between vRNP and
kinesin by co-immunoprecipitation (data not shown). Instead, our
study using EM (Figure 5), as well as membrane flotation assay
(Figure 6) strongly suggested that vRNPs utilize the vesicular
trafficking system for transport to assembly sites. MT motors are
known to drive the transport of intracellular vesicles within the
cell. Rab proteins, which function as key regulators of intracellular
trafficking have been linked to specific MT- or actin-based motor
proteins [37]. We found that mRFP-Rab11a co-localize (Figure 7)
and concomitantly move with vRNP (Figure 8C) in live cells,
which also supports the involvement of intracellular vesicular
trafficking regulated by Rab11a in vRNP translocation. Rab
GTPases have been implicated in the regulation of membrane
traffic, including vesicle budding, tethering/docking to their target
compartments and in the interaction of vesicles with cytoskeletal
elements. Rab proteins are anchored to lipid bilayers via C-
terminal prenylation sites at cysteine residues [38], and regulate
distinct intracellular transport steps through their interaction with
effector proteins. Various Rab11 family of interacting proteins
(Rab11-FIPs), which contain a highly conserved C-terminal Rab
binding domain have been identified [39-40]. One of the Rab11
effector proteins FIP2 has been shown to interact with myosin Vb,
an actin-based motor protein [41]. A ternary complex of Rab11-
FIP2-myosin Vb is likely to provide the link between endosomes
and the cytoskeleton to regulate the delivery of vesicular cargo to
the plasma membrane. Similarly, evidence of direct binding
between Rab11-FIP5/Rip11 and the MT-based motor Kinesin II
was shown [42]. Rab11-FIP5/Rip11 is a Rab11-interacting
protein that is localized to apical recycling endosomes in polarized
Figure 6. Membrane association of NP in infected cells. HeLa cells were infected with rSeVLeGFP for 12 h. The post nuclear supernatants were
prepared in 85% sucrose resulting in a final concentration of 71.5% sucrose, which was layered with 55%, then 10% sucrose solutions. After
centrifugation, thirteen 800 ml fractions were collected. Quantity of NP (dark gray bars) and P (light gray bars) in each fraction was determined by
Western blot analysis using anti-SeV polyclonal antibody and analyzed using Quantity One software. The refractive index of each fraction is denoted
by asterisks. Data are representative of 3 separate experiments. Image of one representative Western blot of NP and P is also shown below the graph.
doi:10.1371/journal.pone.0010994.g006
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non-polarized cells [42], suggesting interactions between the
motor proteins and Rab11/Rab11-FIPs are required for endocytic
apical transport.
Among the Rab proteins, Rab8a and Rab11a have been
identified as being involved in recycling endosomes and Golgi-
plasma membrane trafficking [16,20–21,27,44–45]. However, a
recent study indicates that Rab11a and Rab8a define different
recycling pathways. Rab8a localize to a tubular network
containing EHD1 and EHD3, which does not contain Rab11a.
Live cell imaging also demonstrated distinct pathways for Rab11a
and Rab8a vesicle trafficking [46]. We detected no co-localization
of Rab8a with vRNP, in sharp contrast with the results of Rab11a,
suggesting that the vesicular pathway regulated by Rab11a, but
not Rab8a, is involved in vRNP trafficking. In fact, we detected
vRNP movement in parallel with fluorescently-labeled transferrin
that binds to the transferrin receptor, a quintessential marker of
recycling endosomes (Figure 8D and Video S4). The movement of
the transferrin receptor along the recycling endosome pathway is
regulated by the activation of Rab11, which is required not only
for endocytosis of transferrin into the recycling compartment but
also for direct recycling of the sorting endosomes to the cell surface
[28]. In polarized cells, Rab11 proteins and Rab11-FIPs regulate
apical recycling endosomes, mediating the proper sorting and
targeting of proteins during polarization [39,47–48]. Since SeV is
released from the apical surface of respiratory epithelial cells,
vRNP trafficking regulated by Rab11 may facilitate efficient virus
assembly.
Although little is known about the cellular machinery involved
in the transport of paramyxovirus core structural proteins, the
vesicular trafficking pathway has been implicated in transporting
some components of enveloped RNA viruses to sites of viral
assembly. Marburg virus VP40, the matrix protein, was shown to
be associated with late endosomal compartments. VP40-positive
membranes contained Lamp-1, a marker protein of late
endosomes, and the transferrin receptor. Also, purified Marburg
Figure 7. Co-localization of Rab11a with vRNP. (A) Diagram of constructs showing mRFPs fused to the N-terminus of Rab8a or Rab11a,
including the linker sequence. (B) Western blot analysis of Rab constructs. HeLa cells were transfected with cDNAs expressing mRFP (lane 1), mRFP-
Rab8a (lane 2) or mRFP-Rab11a (lane 3), and lysates were analyzed by Western blot using an anti-RFP antibody. (C and D) Co-localization of mRFP-
Rab11a, but not mRFP-Rab8a with LeGFP. HeLa cells were infected with rSeVLeGFP and transfected with cDNAs that express (C) mRFP-Rab8a or (D)
mRFP-Rab11a. Cells were fixed at 16 h after infection/transfection and observed using confocal microscopy. Left and middle panels show LeGFP and
mRFP-Rab8a or -Rab11a, respectively, and right panels show overlapping degree of intensity, as determined by Olympus FV1000 software.
doi:10.1371/journal.pone.0010994.g007
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were also shown to be the site of Marburg viral envelope formation
[51]. In the case of respiratory syncytial virus (RSV), expression of
a dominant negative form of myosin Vb or the C-terminal
fragment of Rab11-FIP1 reduced viral yield released from the
apical surface of polarized cells [52]. A dominant negative form of
Rab11-FIP2 also reduced the supernatant-associated RSV titer,
suggesting that Rab-FIPs are required for the budding of RSV
[53]. It is not known whether Rab11 and Rab11-FIPs are involved
in vRNP transport and assembly of RSV.
How SeV vRNPs associate with vesicles is an important
question in understanding the process of viral assembly. It is
possible that vRNPs are transported through interactions with
other viral proteins, such as M or envelope glycoproteins. In SeV,
the M protein has been shown to bind the viral glycoproteins,
which are transported to the plasma membrane by means of the
secretory pathway [3]. M also interacts with specific NP, and this
specific interaction is required for incorporation of vRNP into
progeny virions [4]. Because M plays a central role in viral
assembly and budding, it is possible that M interacts with vRNP
not only at the plasma membrane during virion formation, but
also before vRNPs reach the assembly site. Further analysis of the
interaction between viral proteins and Rab and Rab-associated




LLC-MK2 (ATCC, CCL-7), HeLa (ATCC, CCL-2), HeLa T4
+
[54] and 293T [55] cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) with 10% fetal calf serum (FCS). SeV
strain Enders, rSeVLeGFP, and rSeV-eGFP were grown in LLC-
MK2 cells in DMEM supplemented with acetylated trypsin
(2 mg/ml). vTF7.3 [56] was grown in HeLa T4
+ cells.
cDNA synthesis and cloning
The full genome cDNA of rSeVLeGFP (pSeVLeGFP) was
constructed as follows. The cDNA containing the L protein
C-terminus was subcloned from pSeV(E) [57] to plasmid pTF1
[58] and an FseI site was created at the end of the L coding region
using the QuikChange Mutagenesis Kit (Stratagene). The eGFP
gene was amplified by PCR from plasmid pEGFP-N1 (Clontech)
using primers containing FseI sites flanking the gene, and was
inserted into the L gene fragment in pTF1 at the FseI site. The L
gene fused to the eGFP gene was then subcloned back to pSeV(E).
The cDNA of rSeV-eGFP (pSeV-eGFP), which expresses non-
fused eGFP was constructed by inserting the eGFP gene amplified
from pEGFP-N1. The primers used for PCR included transcrip-
tion termination and initiation sites, as well as the restriction (NotI)
site used for the insertion of the gene into pSeV(+)N [59]. Rab8a
Figure 8. Concomitant movement of vRNP with mRFP-Rab11a or transferrin. (A and C) SeV LeGFP (green) in cells constitutively expressing
mRFP-Rab11a (red). Montage illustrating movement of mRFP-Rab11a with LeGFP in boxed area of (A) is shown in (C). (B and D) HeLa cells infected
with rSeVLeGFP were incubated with transferrin-Alexa 594. Montage images of concomitant movement of LeGFP (green) and transferrin (red) in
boxed area of (B) are shown in (D).
doi:10.1371/journal.pone.0010994.g008
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total RNA extracted from HeLa cells. RT-PCR was performed
using Rab8a and Rab11a specific primers, which also include
EcoRI and KpnI sites for subcloning the genes to the pmRFP-C1
vector (Clontech).
Rescue of rSeVLeGFP and rSeV-eGFP
The recombinant SeVs were rescued as described previously
[60]. Briefly, 293T cells infected with vTF7.3 were transfected
with 2 mg of pSeVLeGFP or pSeV-eGFP together with supporting
plasmids pTF1SeVNP (1 mg), pTF1SeVP (1 mg), and pTF1SeVL
(0.1 mg) by Lipofectamine 2000 (Invitrogen). After 36 h incubation
in DMEM supplemented with 0.15% bovine serum albumin plus
araC (40 mg/ml), the cells were treated with trypsin and overlayed
onto LLC-MK2 cells and cultured in DMEM containing trypsin.
The rescued virus was plaque purified in LLC-MK2 cells, and the
stock virus was grown in LLC-MK2 cells.
Establishment of HeLa cells constitutively expressing
Rab11a- or Rab8a-mRFP
The mRFP, mRFP-Rab8a, and mRFP-Rab11a genes were
subcloned from those in pmRFP-C1 plasmids into the pCAGGS-
HygR vector, which contains a hygromycin resistance gene under
IRES. HeLa cells (obtained from ATCC) were transfected with the
cDNAs using CaPO4, and hygromycin resistant colonies were
selected and grown in DMEM containing 8% FCS.
Western blot analysis
To detect expression of LeGFP or eGFP, infected cell lysates
were prepared using TNE buffer (10 mM Tris [pH 7.4], 150 mM
NaCl, 0.5% NP-40, 1 mM EDTA). Proteins in the SDS-PAGE
were electrotransferred onto PVDF membranes and probed with
specific Mab against GFP (Covance). To detect the expression of
Rab8a or Rab11a fused to mRFP, HeLa cells were transfected
with the cDNAs and cell lysates were prepared after 24 h using
TNE buffer and analyzed using anti-RFP antibody (Rockland), as
described above.
Immunofluorescence assays
For the co-localization assay of SeV NP, P or F with LeGFP,
HeLa cells were infected with rSeVLeGFP at MOI 0.8. After
24 h, cells were fixed with 4% paraformaldehyde (PFA) for 15 min
and permeabilized with 0.1% Triton X-100 for 10 min at room
temperature (RT). SeV NP, P and F proteins were detected by
reaction with anti-SeV NP, anti-SeV P or anti-SeV F Mab
followed by goat anti-mouse Texas Red (Molecular Probes).
Co-localization of Rab8a and Rab11a with rSeVLeGFP
HeLa cells were infected with rSeVLeGFP for 1 h, then
transfected with either pmRFP-Rab8a or pmRFP-Rab11a, using
Lipofectamine 2000 (Invitrogen). After overnight incubation at
34uC, cells were fixed with 4% paraformaldehyde and analyzed by
confocal microscopy using a 63X oil immersion objective on an
Olympus FV1000 confocal microscope. The lasers utilized were
488(GFP)at3%and559(RFP)at2.3%withKalmanLine=4.The
data were analyzed using the Olympus FV1000 software (v. 1.7c).
Live cell tracking analysis
HeLa cells in a DT35 dish (Bioptechs) were infected with
rSeVLeGFP for 18 h, then the movement of LeGFP was recorded
using a Leica DMIRB inverted fluorescence microscope equipped
with Image-Pro Plus software (Mediacybernetics) while maintain-
ing the cells at 37uCo naDTC3 temperature-controlled stage.
The video image data was analyzed using NIH ImageJ software.
For visualizing movement of LeGFP along microtubule structures,
infected cells were treated with 250 nM Tubulin Tracker Green
(Molecular Probes) for 30 min at 37uC in PBS(+), and imaged as
above. To observe mRFP-Rab11a movement with vRNPs, the
HeLa-mRFP-Rab11a cells were infected with rSeVLeGFP for
16 h, and observed using an Olympus FV1000 confocal
microscope. A 63X oil immersion objective was utilized, with a
488 (GFP) laser at 9% and a 559 laser (RFP) at 10%. The pinhole
was open to 240, and the resolution was set at 6406640,
2 ms/pixel at 1.5 frames/sec. For the visualization of concomitant
movement of transferrin along with vRNPs, HeLa cells infected
with rSeVLeGFP for 18 h were treated with 5 mg/ml transferrin
conjugated to Alexa 594 (Molecular Probes, Invitrogen) for 30
minutes at 37uC. Cells were analyzed by confocal microscopy,
using a 63X oil immersion objective on an Olympus FV1000
confocal microscope. The lasers utilized were 488 (GFP) at 3%
and 559 (RFP) at 1.5%. Resolution used was 160061600,
12.5 ms/pixel, with a step size of 4.5 mm at 1.5 frames/sec. The
data were analyzed using the Olympus FV1000 software (v. 1.7c).
Additional video editing was performed using Adobe After Effects
CS3 (v. 8.0.2).
Effect of nocodazole on virus replication and production
HeLa cells infected with SeV for 24 h were cultured in labeling
medium containing 100 mCi of
35S-Met/Cys (PerkinElmer) in the
presence or absence of nocodazole (20 mg/ml) for 16 h. Progeny
virions in culture supernatants were purified by ultracentrifuge
over 40% glycerol in PBS, and analyzed by SDS-PAGE. Level of
NP proteins in infected cells was determined by Western blotting
using anti-SeV NP monoclonal antibody. For titration of infectious
virus released into the culture medium, we infected LLC-MK2
cells with SeV at an MOI of 1, and after 4 h incubation, culture
medium was replaced with medium with or without nocodazole at
5 mg/ml. After 20 h incubation, viruses in the medium were
titrated by plaque assay in LLC-MK2 cells.
Electron Microscopy
HeLa cells were infected with rSeVLeGFP or left uninfected for
18 h, and fixed in 4% PFA. The cells were then post-fixed with
1% OSO4 and ultra-thin sections were stained using uranyl
acetate and lead citrate. The images were collected using a Hitachi
7100 transmission electron microscope. For immunoelectron
microscope analysis using 3, 39-Diaminobenzidine (DAB) staining,
fixed and permeabilized cells were treated with blocking solution
(0.8% BSA, 0.1% fish gelatin, 5% normal horse serum, and 0.01%
Triton X-100 in PBS(+)) and reacted with anti-SeV NP Mab
cocktail, followed by incubation with goat anti-mouse IgG
horseradish peroxidase (HRP). After washing, the cells were
stained using the DAB plus substrate kit (Zymed Laboratories,
Inc.). The samples were silver enhanced, treated with 1% osmium
and embedded in Epon. For the immuno-gold reaction, cells were
fixed with 4% PFA and embedded in Lowicryl low melt resin. The
cells were sectioned, placed on grids, and reacted with anti-SeV
NP and goat anti-mouse 12 nm gold beads (Jackson Laboratories).
Membrane Flotation Assay
Assay was performed as previously [61]. Briefly, cells infected
with rSeVLeGFP for 12 h were lysed with hypotonic buffer and
dounce homogenized. Supernatant after brief spin was mixed with
85% sucrose in TNE buffer, resulting in a 71.5% final sucrose
concentration, which was overlayed by 55% and 10% sucrose in
TNE buffer. The samples were centrifuged 18 h at 28,000 rpm
(,100,0006g) in an SW41 rotor at 4uC, and thirteen 800 ml
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by Quantity One image analysis software (Bio-Rad Laboratories)
after Western blotting, using anti-SeV polyclonal serum and rabbit
anti-guinea pig IgG HRP. The refractive index of the fractions was
determined by hand-held refractometer (R-5000, Atago, U.S.A.).
Supporting Information
Video S1 Movement of LeGFP in HeLa cells. Live cells infected
with rSeVLeGFP were observed using a Leica DMIRB inverted
fluorescence microscope equipped with Image-Pro Plus software.
The movements of LeGFP were recorded while maintaining the
cells at 37A ˆuC.
Found at: doi:10.1371/journal.pone.0010994.s001 (5.80 MB
MOV)
Video S2 Trafficking of vRNP along MT. rSeVLeGFP-infected
cells were treated with 250 nM Tubulin Tracker Green and the
movement of LeGFP was recorded as described in Video S1.
Arrows indicate vRNP movements along MT.
Found at: doi:10.1371/journal.pone.0010994.s002 (7.58 MB
MOV)
Video S3 Nocodazole treatment restricts LeGFP trafficking.
HeLa cells infected with rSeVLeGFP were treated with 10 ug/ml
nocodazole for 1 h at 18 h post infection and the movement of
LeGFP was recorded, as described for Video S1.
Found at: doi:10.1371/journal.pone.0010994.s003 (9.95 MB
MOV)
Video S4 Concomitant movement of vRNPs with mRFP-
Rab11a. HeLa-mRFP-Rab11a cells were infected with rSeV-
LeGFP and live cell analysis was performed using an Olympus
FV1000 confocal microscope. Circles indicate LeGFP and mRFP-
Rab11a moving together in the cytoplasm.
Found at: doi:10.1371/journal.pone.0010994.s004 (7.33 MB
MOV)
Video S5 Movement of vRNPs with transferrin. HeLa cells were
infected with rSeVLeGFP and transferrin-Alexa 594 was added.
Trafficking of both transferrin-Alexa 594 and vRNPs was observed
in live cells using the confocal microscope.
Found at: doi:10.1371/journal.pone.0010994.s005 (4.52 MB
MOV)
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